﻿{"id":13229,"date":"2025-10-13T11:40:32","date_gmt":"2025-10-13T04:40:32","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=13229"},"modified":"2025-10-13T11:40:32","modified_gmt":"2025-10-13T04:40:32","slug":"fluorescein-sodium","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/fluorescein-sodium\/","title":{"rendered":"Fluorescein Sodium"},"content":{"rendered":"<p>Soluble Fluorescein<\/p>\n<p>(Ph. Eur. monograph 1213)<\/p>\n<p>C<sub>20<\/sub>H<sub>10<\/sub>Na<sub>2<\/sub>O<sub>5<\/sub>\u00a0 \u00a0 \u00a0 376.3\u00a0 \u00a0 \u00a0 \u00a0518-47-8<\/p>\n<p><strong>Action and use<\/strong><\/p>\n<p>Detection of corneal lesions, retinal angiography and pancreatic function testing.<\/p>\n<p><strong>Preparations<\/strong><\/p>\n<p>Fluorescein Eye Drops<\/p>\n<p>Fluorescein Injection<\/p>\n<h2>DEFINITION<\/h2>\n<p>Disodium 2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate.<\/p>\n<h3>Content<\/h3>\n<p>95.0 per cent to 103.0 per cent (dried substance).<\/p>\n<h2>CHARACTERS<\/h2>\n<h3>Appearance<\/h3>\n<p>Orange-red, fine powder, hygroscopic.<\/p>\n<h3>Solubility<\/h3>\n<p>Freely soluble in water, soluble in ethanol (96 per cent), practically insoluble in hexane and in methylene chloride.<\/p>\n<h2>IDENTIFICATION<\/h2>\n<p>First identification: B, D.<\/p>\n<p>Second identification: A, C, D.<\/p>\n<p>A. Dilute 0.1 mL of solution S (see Tests) to 10 mL with water R. The solution shows yellowish-green fluorescence. The fluorescence disappears on addition of 0.1 mL of dilute hydrochloric acid R and reappears on addition of 0.2 mL of dilute sodium hydroxide solution R.<\/p>\n<p>B. Infrared absorption spectrophotometry (2.2.24).<\/p>\n<p>Preparation: Discs.<\/p>\n<p>Comparison: Ph. Eur. reference spectrum of fluorescein sodium.<\/p>\n<p>C. The absorption by a piece of filter paper of 0.05 mL of the solution prepared for identification A (before the addition of dilute hydrochloric acid R) colours the paper yellow. On exposing the moist paper to bromine vapour for 1 min and then to ammonia vapour, the colour becomes deep pink.<\/p>\n<p>D. Ignite 0.1 g in a porcelain crucible. Dissolve the residue in 5 mL of water R and filter. 2 mL of the filtrate gives reaction (a) of sodium (2.3.1).<\/p>\n<h2>TESTS<\/h2>\n<h3>Solution S<\/h3>\n<p>Dissolve 1.0 g in carbon dioxide-free water R prepared from distilled water R and dilute to 50 mL with the same solvent.<\/p>\n<h3>Appearance of solution<\/h3>\n<p>Solution S is clear (2.2.1) and orange-yellow with yellowish-green fluorescence.<\/p>\n<h4>pH (2.2.3)<\/h4>\n<p>7.0 to 9.0 for solution S.<\/p>\n<h3>Related substances<\/h3>\n<p>Liquid chromatography (2.2.29).<\/p>\n<p>Test solution (a): Dissolve 0.100 g of the substance to be examined in a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A and dilute to 100.0 mL with the same mixture of solvents.<\/p>\n<p>Test solution (b): Dilute 5.0 mL of test solution (a) to 250.0 mL with a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A.<\/p>\n<p>Reference solution (a): Dissolve 55.0 mg of diacetylfluorescein CRS in a mixture of 1 mL of 2.5 M sodium hydroxide and 5 mL of ethanol (96 per cent) R, heat on a water-bath for 20 min mixing frequently, cool and dilute to 50.0 mL with water R. Dilute 5.0 mL of the solution to 250.0 mL with a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A.<\/p>\n<p>Reference solution (b): Dissolve 10.0 mg of phthalic acid R (impurity B) and 10.0 mg of resorcinol R (impurity A) in a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A and dilute to 100.0 mL with the same mixture of solvents. Dilute 5.0 mL of the solution to 100.0 mL with a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A.<\/p>\n<p>Reference solution (c): Dilute 5.0 mL of test solution (b) to 20.0 mL with a mixture of 30 volumes of acetonitrile R and 70 volumes of mobile phase A.<\/p>\n<p>Column:<\/p>\n<p>\u2014 size: l = 0.25 m, \u00d8 = 4.6 mm;<\/p>\n<p>\u2014 stationary phase: octylsilyl silica gel for chromatography R (5 \u03bcm);<\/p>\n<p>\u2014 temperature: 35 \u00b0C.<\/p>\n<p>Mobile phase:<\/p>\n<p>\u2014 mobile phase A: dissolve 0.610 g of potassium dihydrogen phosphate R in water R and dilute to 1000 mL with the same solvent; adjust to pH 2.0 with phosphoric acid R;<\/p>\n<p>\u2014 mobile phase B: acetonitrile for chromatography R;<\/p>\n<table style=\"border-collapse: collapse; width: 100%; height: 127px;\">\n<tbody>\n<tr style=\"height: 43px;\">\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Time<\/strong><br \/>\n<strong>(min)<\/strong><\/td>\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Mobile phase A<\/strong><br \/>\n<strong>(per cent V\/V)<\/strong><\/td>\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Mobile phase B<\/strong><br \/>\n<strong>(per cent V\/V)<\/strong><\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">0 &#8211; 20<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">85 \u2192 20<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">15 \u2192 80<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">20 &#8211; 29<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">20<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">80<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">29 &#8211; 30<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">20 \u2192 85<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">80 \u2192 15<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">30 &#8211; 35<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">85<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">15<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Flow rate: 1.0 mL\/min.<\/p>\n<p>Detection: Spectrophotometer at 220 nm.<\/p>\n<p>Injection: 20 \u03bcL of test solution (a) and reference solutions (b) and (c).<\/p>\n<p>Relative retention: With reference to fluorescein (retention time = about 15 min): impurity A = about 0.4; impurity B = about 0.5; impurity C = about 0.9.<\/p>\n<p>System suitability: Reference solution (b):<\/p>\n<p>\u2014 resolution: minimum 1.5 between the peaks due to impurity A and impurity B.<\/p>\n<p>Limits:<\/p>\n<p>\u2014 correction factor: for the calculation of content, multiply the peak area of impurity C by 1.6;<\/p>\n<p>\u2014 impurities A, B: for each impurity, not more than the area of the corresponding peak in the chromatogram obtained with reference solution (b) (0.5 per cent);<\/p>\n<p>\u2014 impurity C: not more than the area of the principal peak in the chromatogram obtained with reference solution (c)(0.5 per cent);<\/p>\n<p>\u2014 unspecified impurities: for each impurity, not more than 0.2 times the area of the principal peak in the chromatogram obtained with reference solution (c) (0.10 per cent);<\/p>\n<p>\u2014 sum of impurities other than A, B, C: not more than the area of the principal peak in the chromatogram obtained with reference solution (c) (0.5 per cent);<\/p>\n<p>\u2014 disregard limit: 0.1 times the area of the principal peak in the chromatogram obtained with reference solution (c) (0.05 per cent).<\/p>\n<h3>Chlorides (2.4.4)<\/h3>\n<p>Maximum 0.25 per cent.<\/p>\n<p>To 10 mL of solution S add 90 mL of water R and 1 mL of dilute nitric acid R, wait for at least 10 min and filter. Dilute 10 mL of the filtrate to 15 mL with water R.<\/p>\n<h3>Sulfates (2.4.13)<\/h3>\n<p>Maximum 1.0 per cent.<\/p>\n<p>To 5 mL of solution S add 90 mL of distilled water R, 2.5 mL of dilute hydrochloric acid R and dilute to 100 mL with distilled water R. Filter.<\/p>\n<h4>Zinc<\/h4>\n<p>Dilute 5 mL of solution S to 10 mL with water R. Add 2 mL of hydrochloric acid R1, filter and add 0.1 mL of potassium ferrocyanide solution R. No turbidity or precipitate is formed immediately.<\/p>\n<h4>Loss on drying (2.2.32)<\/h4>\n<p>Maximum 10.0 per cent, determined on 1.000 g by drying in an oven at 105 \u00b0C.<\/p>\n<h2>ASSAY<\/h2>\n<p>Liquid chromatography (2.2.29) as described in the test for related substances with the following modification.<\/p>\n<p>Injection Test solution (b) and reference solution (a).<\/p>\n<p>Calculate the percentage content of C<sub>20<\/sub>H<sub>10<\/sub>Na<sub>2<\/sub>O<sub>5<\/sub> using the chromatogram obtained with reference solution (a) and the declared content of diacetylfluorescein CRS.<\/p>\n<p>1 mg of diacetylfluorescein CRS is equivalent to 0.9037 mg of C<sub>20<\/sub>H<sub>10<\/sub>Na<sub>2<\/sub>O<sub>5<\/sub>.<\/p>\n<h2>STORAGE<\/h2>\n<p>In an airtight container, protected from light.<\/p>\n<h2>IMPURITIES<\/h2>\n<p>Specified impurities A, B, C.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-13239\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-A-300x163.jpg\" alt=\"Fluorescein Sodium\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-A-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-A-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-A-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-A.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>A. benzene-1,3-diol (resorcinol),<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-13240\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-B-300x163.jpg\" alt=\"Fluorescein Sodium\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-B-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-B-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-B-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-B.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>B. benzene-1,2-dicarboxylic acid (phthalic acid),<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-13241\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-C-300x163.jpg\" alt=\"Fluorescein Sodium\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-C-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-C-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-C-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/10\/Fluorescein-Sodium-C.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>C. 2-(2,4-dihydroxybenzoyl)benzoic acid.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Soluble Fluorescein (Ph. Eur. monograph 1213) C20H10Na2O5\u00a0 \u00a0 \u00a0 376.3\u00a0 \u00a0 \u00a0 \u00a0518-47-8 Action and use Detection of corneal lesions, retinal angiography and pancreatic function testing. Preparations Fluorescein Eye Drops Fluorescein Injection DEFINITION Disodium 2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate. Content 95.0 per cent to 103.0 per cent (dried substance). CHARACTERS Appearance Orange-red, fine powder, hygroscopic. Solubility Freely soluble in&#8230;<\/p>\n","protected":false},"author":2,"featured_media":13238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-13229","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/13229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=13229"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/13229\/revisions"}],"predecessor-version":[{"id":13246,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/13229\/revisions\/13246"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/13238"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=13229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=13229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=13229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}